<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112718">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025166</url>
  </required_header>
  <id_info>
    <org_study_id>RMB343-13</org_study_id>
    <secondary_id>RMB0343-13</secondary_id>
    <nct_id>NCT02025166</nct_id>
  </id_info>
  <brief_title>Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion</brief_title>
  <official_title>Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare between the efficacy of Paracetamol  IV vs. Lornoxicam IV in pain relief
      following surgical abortion.

      The medication will be given at the time of the procedure. Following the abortion, pain
      level will be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with medical indication for surgical abortion during first trimester will be
      divided to two groups. The study groups, the surgeons and the nurses will be blinded to one
      of the treatment arms.

      Pain will be evaluated at fixed intervals following the abortion. Comparison in pain levels
      between the study groups will be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>Two hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain level will be evaluated by VAS</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pain treatment, aniline analgesics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lornoxicam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pain treatment, nonsteroidal anti-inflammatory (NSAID)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>Pain treatment with &quot;aniline analgesics&quot; (paracetamol) at the time of the procedure</description>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_label>lornoxicam</arm_group_label>
    <other_name>Pain relief</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lornoxicam</intervention_name>
    <description>Pain treatment with &quot;NSAID&quot; (lornoxicam) at the time of the procedure</description>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_label>lornoxicam</arm_group_label>
    <other_name>Pain relief</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective surgical abortion for first trimester pregnancy

        Exclusion Criteria:

          -  Chronic pelvic pain

          -  Fibromyalgia

          -  Pelvic inflammatory disease

          -  Chronic renal failure, liver disease, peptic ulcer

          -  cervical stenosis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susana Mustafa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nibal Awad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lior Lowenstein, MD, MS</last_name>
    <phone>97248542653</phone>
    <email>l_lior@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lior Lowenstein, MD, MS</last_name>
      <phone>972502061434</phone>
      <email>l_lior@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Susana Mustafa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 30, 2013</lastchanged_date>
  <firstreceived_date>December 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Lior Lowenstein</investigator_full_name>
    <investigator_title>Gynecologist</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>abortion</keyword>
  <keyword>paracetamol</keyword>
  <keyword>lornoxicam</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Lornoxicam</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
